Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
INHIBITORS OF SARM1
Document Type and Number:
WIPO Patent Application WO/2021/142006
Kind Code:
A1
Abstract:
The present disclosure provides compounds and methods useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration.

Inventors:
BENTLEY JONATHAN (GB)
BOSANAC TODD (US)
BREARLEY ANDREW SIMON (GB)
COOPER SOPHIE CATHERINE (GB)
DEVRAJ RAJESH (US)
HUGHES ROBERT OWEN (US)
JARJES-PIKE RICHARD ANDREW (GB)
MARLIN FRÉDÉRIC JACQUES (GB)
PARROTT SHELLEY ANNE (GB)
SILVA DANIEL (GB)
Application Number:
PCT/US2021/012333
Publication Date:
July 15, 2021
Filing Date:
January 06, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DISARM THERAPEUTICS INC (US)
International Classes:
C07D401/04; A61K31/4439; A61P25/00; C07D401/14; C07D405/04; C07D409/14; C07D413/14; C07D417/04; C07D471/04; C07D491/04
Domestic Patent References:
WO2004096797A12004-11-11
WO2009080705A22009-07-02
WO2010093849A22010-08-19
WO2002088113A12002-11-07
WO2008034600A12008-03-27
WO2018107056A12018-06-14
WO2006065946A12006-06-22
WO2019236890A12019-12-12
WO2018057989A12018-03-29
Foreign References:
US20090163469A12009-06-25
US20040157861A12004-08-12
US20040122016A12004-06-24
US20050272779A12005-12-08
EP2036905A12009-03-18
US20060019956A12006-01-26
Other References:
GREEN ET AL.: "Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors", J. MED. CHEM., vol. 58, no. 12, 12 June 2015 (2015-06-12), US, pages 5028 - 5037, XP055613567, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.5b00424
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ALEKSEEVA ET AL.: "Preparation of 3-acylaminopyridine derivatives as serine-threonine protein kinase GSK3B inhibitors for the treatment of type II diabetes", XP055779402, retrieved from STN Database accession no. 2015:2051338
GERDTS ET AL.: "SARM1 activation triggers axon degeneration locally via NAD(+) destruction", SCIENCE, vol. 348, 2016, pages 453 - 457, XP055431673, DOI: 10.1126/science.1258366
S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, vol. 66, pages 1 - 19
GERDTS, J. ET AL., NEURON, vol. 89, 2016, pages 449 - 460
WHITMORE, A.V. ET AL., CELL DEATH DIFFER., vol. 10, 2003, pages 260 - 261
BELENKEY ET AL., TRENDS BIOCHEM, vol. 32, 2007, pages 12 - 19
CHIARUGI ET AL., NAT. REV. CANCER, vol. 12, 2012, pages 741 - 752
BABETTO ET AL., CELL REP., vol. 3, 2010, pages 1422 - 1429
SASAKI ET AL., J. NEUROSCI., 2009
GERDTS ET AL., J NEUROSCI, vol. 33, 2013, pages 13569 - 13580
O'NEILL, L.A.BOWIE, A.G., NAT. REV. IMMUNOL., vol. 7, 2007, pages 353 - 364
OSTERLOH, J.M. ET AL., SCIENCE, vol. 337, 2012, pages 481 - 484
GERDTS, J. ET AL., J. NEUROSCI., vol. 33, 2013, pages 13569 - 13580
GERDTS, J. ET AL., SCIENCE, vol. 348, 2015, pages 452 - 457
SASAKI ET AL., J. BIOL. CHEM., vol. 290, 2015, pages 17228 - 17238
HENNINGER, N. ET AL., BRAIN, vol. 139, 2016, pages 3092 - 3108
TEWARI, R. ET AL., TRENDS CELL BIOL., vol. 20, 2010, pages 470 - 481
QIAO, F.BOWIE, J.U., SCI. STKE, vol. 2005, 2005, pages re7
SAMBROOK, J. ET AL.: "Molecular Cloning: A Laboratory Manual", 2001, COLD SPRING HARBOR LABORATORY PRESS
"Remington: the Science and Practice of Pharmacy", 1995, HUMANA PRESS
SPECTOR, D. L. ET AL.: "Cells: A Laboratory Manual", 1998, COLD SPRING HARBOR LABORATORY PRESS
HARLOW, E.: "Using Antibodies: A Laboratory Manual", 1999, COLD SPRING HARBOR LABORATORY PRESS
HARDMAN, J.G. ET AL.: "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 1996, MCGRAW-HILL
ROWE, R.C. ET AL.: "Handbook of Pharmaceutical Excipients", 2003, PHARMACEUTICAL PRESS
Attorney, Agent or Firm:
LENTZ, Nelsen, L. et al. (US)
Download PDF: